Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.
Quick Facts
What This Study Found
E7-LP35 vaccine showed significantly higher antitumor activity compared to E7-SP and E7-LP20 vaccines.
Key Numbers
How They Did This
The study utilized mouse TC-1 tumor models to compare the antitumor activity of different flagellin-adjuvanted peptide vaccines.
Why This Research Matters
This research highlights the potential of combining cancer vaccines with immune checkpoint inhibitors to improve treatment outcomes. It may lead to more effective therapies for HPV-related cancers.
What This Study Doesn't Tell Us
The study was conducted in mouse models, which may not fully translate to human responses. Further research is needed to confirm these findings in clinical settings.
Trust & Context
- Original Title:
- Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.
- Published In:
- Translational cancer research, 11(6), 1595-1602 (2022)
- Authors:
- Lee, Hye Hwa, Hong, Seol Hee, Rhee, Joon Haeng, Lee, Shee Eun
- Database ID:
- RPEP-06290
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06290APA
Lee, Hye Hwa; Hong, Seol Hee; Rhee, Joon Haeng; Lee, Shee Eun. (2022). Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.. Translational cancer research, 11(6), 1595-1602. https://doi.org/10.21037/tcr-21-2798
MLA
Lee, Hye Hwa, et al. "Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.." Translational cancer research, 2022. https://doi.org/10.21037/tcr-21-2798
RethinkPeptides
RethinkPeptides Research Database. "Optimal long peptide for flagellin-adjuvanted HPV E7 cancer ..." RPEP-06290. Retrieved from https://rethinkpeptides.com/research/lee-2022-optimal-long-peptide-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.